巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Neuronetics

    STIM
    4.290
    0.130
    2.94%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Neuronetics - 延遲價格・最後更新於 16/08 12:00
    最高位
    4.430
    最低位
    4.290
    開市價
    --
    前收市價
    4.420
    成交量(千)
    2.20
    成交額(百萬)
    0.09
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    115.93
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    8.540 - 1.980
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Neuronetics
    證券代碼
    STIM.US
    所屬板塊
    Diagnostics & Research
    公司業務
    Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
    發行量
    27022796
    公司總部
    3222 Phoenixville Pike
    公司網址
    https://www.neurostar.com
    公司電郵
    ir@neuronetics.com
    公司電話
    +1 610 640-4202
    暫無內容

    關於

    Neuronetics(STIM.US)所屬的行業板塊為Diagnostics & Research。
    Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
    詳細公司背景可參考: https://www.neurostar.com